logo
Select company
Select metric
-96.96%Return on Assets
VS
Market
7
Sector
20
Industry
27
History
18
$ 2.97Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information

Ticker

XFOR

Company Name

X4 PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

X4 PHARMACEUTICALS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XFOR - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 105.17M$ -101.98M-96.96%
3/31/2025$ 130.01M$ 14.6M11.23%
12/31/2024$ 146.45M$ -37.45M-25.57%
9/30/2024$ 178.16M$ -16.76M-9.41%
6/30/2024$ 210.61M$ 17.63M8.37%
3/31/2024$ 112.18M$ -128.91M-114.91%
12/31/2023$ 147.26M$ -101.17M-68.7%
9/30/2023$ 173.29M$ -111.14M-64.13%
6/30/2023$ 173.4M$ -130.71M-75.38%
3/31/2023$ 124.41M$ -96.21M-77.34%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROA stands at -40.99%.
  • Over the past 5 years, X4 PHARMACEUTICALS INC's average ROA has been -62.39%.
  • The median ROA for X4 PHARMACEUTICALS INC during this period was -66.42%
  • X4 PHARMACEUTICALS INC reached its highest ROA over the past 5 years at 11.23%.
  • The lowest ROA recorded by X4 PHARMACEUTICALS INC in the same timeframe -125.31%

X4 PHARMACEUTICALS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
AMS : AMERICAN SHARED HOSPITAL SERVICES -3.84%BNGO : BIONANO GENOMICS INC -97.79%CRIS : CURIS INC -133.13%MRKR : MARKER THERAPEUTICS INC -98.91%LPCN : LIPOCINE INC -24.26%DRIO : DARIOHEALTH CORP -54.92%GBIO : GENERATION BIO CO -40.36%BCAB : BIOATLA INC -219.38%CARM : CARISMA THERAPEUTICS INC -985.18%PULM : PULMATRIX INC -124.85%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for X4 PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -54.57M ] / Assets [ $ 133.13M ]
(=) ROA [ -40.99% ]

XFOR - Return on Assets, Last 5 years

-125.31%

Minimum

Jun 30, 2022

11.23%

Maximum

Mar 31, 2025

-62.39%

Average

-66.42%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.45K
min-33.42%
max33.98%
average0.1%
median1.53%
std10.63%